Olympus

Olympus Corp. of the Americas Named Founders Award Winner

Retrieved on: 
Thursday, July 6, 2023

CENTER VALLEY, Pa., July 6, 2023 /PRNewswire/ -- Olympus Corp. of the Americas (OCA) announced today that it received the Founders Award for its efforts in providing career advancement opportunities for its administrative professionals.

Key Points: 
  • Presented by the Philadelphia chapter of the Admin Awards, the Founders Award recognizes companies that provide exceptional opportunities for career advancement in both title and compensation for administrative professionals.
  • The Founders Award recognizes OCA for its Olympus Administrative Assistant Alliance initiative or OA3.
  • Formed in 2016, OA3 launched with a goal of nurturing a work environment that supports continuing education, creativity and camaraderie.
  • Traveling between the U.S. and Japan, she toured Olympus facilities in Japan, worked to improve CAPA processes and provide trainings.

Civitas Resources to Enter Permian Basin through Transformative Transactions

Retrieved on: 
Tuesday, June 20, 2023

The transactions will fundamentally transform Civitas into a stronger, more balanced, and sustainable enterprise with a deep inventory of high-return drilling opportunities in the heart of the Permian and DJ basins.

Key Points: 
  • The transactions will fundamentally transform Civitas into a stronger, more balanced, and sustainable enterprise with a deep inventory of high-return drilling opportunities in the heart of the Permian and DJ basins.
  • Civitas plans to hold a conference call to discuss the transactions at 6:30 a.m. MDT (8:30 a.m. EDT) on June 20, 2023.
  • Balanced portfolio maximizes capital allocation flexibility: Post close, Civitas will have a more balanced asset portfolio with basin and commodity diversity.
  • “These accretive and transformative transactions will immediately create a stronger, more balanced and sustainable Civitas,” said Chris Doyle, Civitas President & CEO.

MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator

Retrieved on: 
Wednesday, June 7, 2023

MedTech Innovator , the world’s largest accelerator of medical technology companies announced today that 24 medtech companies will participate in the fourth annual Asia Pacific Accelerator program.

Key Points: 
  • MedTech Innovator , the world’s largest accelerator of medical technology companies announced today that 24 medtech companies will participate in the fourth annual Asia Pacific Accelerator program.
  • MedTech Innovator Asia Pacific offers best-in-class startups opportunities to work with investors, business leaders and allied service professionals in the medtech industry to help drive commercialization of life-changing technologies throughout the region.
  • “As the world’s largest accelerator of medtech companies, MedTech Innovator established the Asia Pacific Program in 2019 because of the incredible innovation in the region.
  • The 24 companies selected to the 2023 MedTech Innovator Asia Pacific Accelerator are:

Olympus Announces Launch of Next Generation Electrosurgical Generator

Retrieved on: 
Tuesday, June 6, 2023

The ESG-410 Electrosurgical Generator, with its accessories and ancillary equipment, is intended for cutting and coagulation of tissue in open, laparoscopic and endoscopic surgery and should only be used by a qualified physician in an adequate medical environment.

Key Points: 
  • The ESG-410 Electrosurgical Generator, with its accessories and ancillary equipment, is intended for cutting and coagulation of tissue in open, laparoscopic and endoscopic surgery and should only be used by a qualified physician in an adequate medical environment.
  • Improper use or use of incompatible equipment with this electrosurgical generator can lead to excessive or incorrect HF and cause thermal or other injuries for the patient and/or operator.
  • Be aware that if the mains plug is accidentally disconnected during a procedure, the electrosurgical generator immediately turns off and this can result in complications for the patient.
  • At Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling.

Olympus Set to Demonstrate Newest Endoscopy System at DDW

Retrieved on: 
Thursday, May 4, 2023

CENTER VALLEY, Pa., May 4, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today that, for the first time in the U.S., it will demonstrate the EVIS X1™ endoscopy system, its most advanced endoscopy system, at the Digestive Disease Week (DDW) annual meeting May 6-9 in Chicago.

Key Points: 
  • Narrow Band Imaging™: NBI™ technology continues to be featured in the EVIS X1 endoscopy system.
  • Olympus encourages interested parties to visit the Olympus booth #3820 during DDW for hands-on demonstrations of the EVIS X1 endoscopy system.
  • Visit the Olympus booth during DDW or the gastroenterology product page for more information on the complete GI portfolio.
  • Information about the EVIS X1 Endoscopy System will be available on the Olympus website .

Olympus Highlights Minimally Invasive Treatment Options at AUA

Retrieved on: 
Monday, April 24, 2023

CENTER VALLEY, Pa., April 24, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, will highlight its minimally invasive portfolio for the treatment of enlarged prostate, urinary stones and bladder cancer during the American Urology Association (AUA) annual meeting April 28-May 1 in Chicago.

Key Points: 
  • The Olympus booth will feature hands-on demonstrations of:
    ShockPulse-SE™ system, SOLTIVE™ Premium SuperPulsed Laser System and EMPOWER™ laser for kidney and bladder stone management.
  • A versatile electrode portfolio for plasma resection and vaporization for the treatment of BPH and bladder tumors, including the PlasmaButton™ and PlasmaLoop™ electrodes.
  • Olympus will also highlight its expanded stone management portfolio, including the Mini-PCNL system and new stone retrieval baskets.
  • Visit the Olympus booth, #3015, during AUA and the urology product page for information on the complete urology portfolio.

Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets

Retrieved on: 
Thursday, April 20, 2023

HAMBURG, Germany, April 20, 2023 /PRNewswire/ -- Olympus today announced the launch of EndoClot® Adhesive (ECA), EndoClot® Polysaccharide Hemostatic Spray (PHS) and EndoClot® Submucosal Injection Solution (SIS) in the Europe, Middle East and Africa (EMEA) region. This innovative portfolio is developed by EndoClot Plus, Inc. (EPI), which expanded its distribution agreement with Olympus from the U.S. to EMEA in December 2022.

Key Points: 
  • HAMBURG, Germany, April 20, 2023 /PRNewswire/ -- Olympus today announced the launch of EndoClot® Adhesive (ECA), EndoClot® Polysaccharide Hemostatic Spray (PHS) and EndoClot® Submucosal Injection Solution (SIS) in the Europe, Middle East and Africa (EMEA) region.
  • This innovative portfolio is developed by EndoClot Plus, Inc. (EPI), which expanded its distribution agreement with Olympus from the U.S. to EMEA in December 2022.
  • "We are excited to expand our global partnership with EndoClot Plus, Inc.
  • By contributing to safe treatment in gastrointestinal procedures, we aim to improve patient outcomes and hereby elevate the standard or care."

ATLAS HOLDINGS AND OLYMPUS PARTNERS ANNOUNCE DEFINITIVE AGREEMENT FOR THE SALE OF INTERNATIONAL WIRE GROUP HOLDINGS, INC.

Retrieved on: 
Friday, April 14, 2023

GREENWICH, Conn. and STAMFORD, Conn., April 14, 2023 /PRNewswire/ -- Atlas Holdings ("Atlas") and Olympus Partners ("Olympus") jointly announced today the signing of a definitive agreement whereby Olympus will acquire a majority ownership stake in International Wire Group Holdings, Inc. ("IWG").

Key Points: 
  • GREENWICH, Conn. and STAMFORD, Conn., April 14, 2023 /PRNewswire/ -- Atlas Holdings ("Atlas") and Olympus Partners ("Olympus") jointly announced today the signing of a definitive agreement whereby Olympus will acquire a majority ownership stake in International Wire Group Holdings, Inc. ("IWG").
  • Following the close of the transaction, longtime industry leader Gregory J. Smith will continue as President and Chief Executive Officer of IWG.
  • We are looking forward to continuing to support the company in this new chapter with Olympus Partners," said Atlas Partner Neil Mahajan.
  • "I remain deeply proud of our team and all we have accomplished together in making IWG the best wire fabricator in the industry.

Evident Acquired by Bain Capital: Partnership to Accelerate Future Growth and Innovation

Retrieved on: 
Monday, April 3, 2023

TOKYO, April 03, 2023 (GLOBE NEWSWIRE) -- Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive agreement signed on August 29, 2022.

Key Points: 
  • TOKYO, April 03, 2023 (GLOBE NEWSWIRE) -- Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive agreement signed on August 29, 2022.
  • Evident was newly established on April 1, 2022 as a wholly owned subsidiary of Olympus comprising the former Scientific Solutions business conducted by Olympus.
  • Headquartered in Tokyo, Japan, Evident conducts business in 24 countries worldwide with more than 4,300 employees.
  • Supported by Bain Capital, Evident will attain a higher level of agility and faster decision-making to drive innovation-based growth in the life science and industrial markets.

Global ENT Surgical Energy Device (MedCore) Market Analysis Report 2023-2029: Focus on Capital Equipment and Radiofrequency (RF) and Ultrasonic Probes - ResearchAndMarkets.com

Retrieved on: 
Monday, April 10, 2023

The "Global ENT Surgical Energy Device Market Size, Share, & COVID-19 Impact Analysis 2023-2029 - MedCore - Includes: Capital Equipment and Radiofrequency (RF) and Ultrasonic Probes" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global ENT Surgical Energy Device Market Size, Share, & COVID-19 Impact Analysis 2023-2029 - MedCore - Includes: Capital Equipment and Radiofrequency (RF) and Ultrasonic Probes" report has been added to ResearchAndMarkets.com's offering.
  • The global market for ENT surgical energy devices had a valuation of $479.3 million in 2022.
  • The comprehensive report covers capital equipment, as well as radiofrequency (RF) and ultrasonic probes used in ENT surgery.
  • The primary factor driving the ENT surgical energy device market is the level of precision these devices provide during ENT procedures.